297 related articles for article (PubMed ID: 31207277)
1. Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.
Nio Y; Sasai M; Akahori Y; Okamura H; Hasegawa H; Oshima M; Watashi K; Wakita T; Ryo A; Tanaka Y; Hijikata M
Antiviral Res; 2019 Sep; 169():104537. PubMed ID: 31207277
[TBL] [Abstract][Full Text] [Related]
2. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals.
Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V
J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895
[TBL] [Abstract][Full Text] [Related]
3. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells.
Tseng CK; Hsu SP; Lin CK; Wu YH; Lee JC; Young KC
Antiviral Res; 2017 Oct; 146():191-200. PubMed ID: 28935193
[TBL] [Abstract][Full Text] [Related]
4. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
5. A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection.
Zhang K; Lai X; Song J; He L; Wang L; Ou G; Tian X; Wang L; Deng J; Zhang J; Li C; Zhuang H; Li T; Xiang K
Antiviral Res; 2021 May; 189():105061. PubMed ID: 33705864
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Shih YF; Liu CJ
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.
Lee JC; Tseng CK; Young KC; Sun HY; Wang SW; Chen WC; Lin CK; Wu YH
Br J Pharmacol; 2014 Jan; 171(1):237-52. PubMed ID: 24117426
[TBL] [Abstract][Full Text] [Related]
9. A hepatitis B virus causes chronic infections in equids worldwide.
Rasche A; Lehmann F; Goldmann N; Nagel M; Moreira-Soto A; Nobach D; de Oliveira Carneiro I; Osterrieder N; Greenwood AD; Steinmann E; Lukashev AN; Schuler G; Glebe D; Drexler JF;
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33723007
[TBL] [Abstract][Full Text] [Related]
10. Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.
Chen WC; Wang SY; Chiu CC; Tseng CK; Lin CK; Wang HC; Lee JC
Antimicrob Agents Chemother; 2013 Mar; 57(3):1180-91. PubMed ID: 23254429
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses.
Otoguro T; Tanaka T; Kasai H; Kobayashi N; Yamashita A; Fukuhara T; Ryo A; Fukai M; Taketomi A; Matsuura Y; Moriishi K
Hepatol Commun; 2021 Apr; 5(4):634-649. PubMed ID: 33860122
[TBL] [Abstract][Full Text] [Related]
12. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.
Yu JS; Chen WC; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
PLoS One; 2016; 11(3):e0152236. PubMed ID: 27023634
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies.
Su YT; Chang ML; Chien RN; Liaw YF
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146665
[TBL] [Abstract][Full Text] [Related]
15. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
18. The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.
Gallay P; Ure D; Bobardt M; Chatterji U; Ou J; Trepanier D; Foster R
PLoS One; 2019; 14(6):e0217433. PubMed ID: 31181107
[TBL] [Abstract][Full Text] [Related]
19. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication.
Korba BE; Montero AB; Farrar K; Gaye K; Mukerjee S; Ayers MS; Rossignol JF
Antiviral Res; 2008 Jan; 77(1):56-63. PubMed ID: 17888524
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).
Blackard JT; Sherman KE
Rev Med Virol; 2018 Jul; 28(4):e1984. PubMed ID: 29761585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
